Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Alpa J, Dherai"'
Publikováno v:
Journal of clinical pharmacology. Wiley-Blackwell
Although biological agents have revolutionized the management of inflammatory bowel diseases (IBDs), a significant proportion of patients show primary non-response or develop secondary loss of response. Therapeutic drug monitoring (TDM) is advocated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c7a10dd1d80785f2b924eaa4be0e1d5
https://doi.org/10.1002/jcph.2189
https://doi.org/10.1002/jcph.2189
Publikováno v:
Journal of gastroenterology and hepatologyReferences.
Inflammatory bowel disease (IBD) is a chronic gastrointestinal disease of unknown etiology, involving complex interactions between the gut microbiome and host immune response. The microbial dysbiosis is well documented in IBD and significantly influe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cc65de255f80cc857639ca193c64428
https://pubmed.ncbi.nlm.nih.gov/36287112
https://pubmed.ncbi.nlm.nih.gov/36287112
Autor:
Shilpa D Kulkarni, Tester F. Ashavaid, Ganesh R. Bhagure, Vrajesh Udani, Alpa J. Dherai, Rohan V. Lokhande
Publikováno v:
Indian Journal of Pediatrics. 88:1241-1243
Biogenic amine neurotransmitters metabolism is a multistep pathway with pterin and pyridoxal phosphate (vitamin B6) as cofactors. A defect in biogenic amine and cofactor metabolism and vesicular transporters result in a primary neurotransmitter disor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6fb87f4447e5b1c31561fe17c9c96ce1
https://doi.org/10.1007/s12098-021-03956-6
https://doi.org/10.1007/s12098-021-03956-6
Autor:
Prasad R. Naik, Ganesh R. Bhagure, Rohan V. Lokhande, Vrajesh Udani, Tester F. Ashavaid, Neelu Desai, Alpa J. Dherai
Publikováno v:
Indian J Clin Biochem
Biogenic amine neurotransmitters such as serotonin and dopamine are essential for signaling in both central and peripheral nervous system. Their metabolism is a multistep pathway and any defect in this results in alteration in metabolites of serotoni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6a00774e5f08ecd904d80ac4ea549fb
https://doi.org/10.1007/s12291-020-00949-8
https://doi.org/10.1007/s12291-020-00949-8
Publikováno v:
Indian J Clin Biochem
Advances in molecular sequencing technology has increased the diagnostic yield for Congenital disorder of glycosylation (CDG). However, novel variants or those of uncertain significance (vus) often pose a challenge and in such cases confirmed diagnos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c33f65efe91dd27bbb22b3060a20b761
https://doi.org/10.1007/s12291-020-00930-5
https://doi.org/10.1007/s12291-020-00930-5
Autor:
Tester F. Ashavaid, Dhanashri Shetty, Mihika B. Dave, Alpa J. Dherai, Devendra Desai, Satish Kulkarni, Bhamini G Keny, Kiran Peddy
Publikováno v:
Indian Journal of Gastroenterology. 39:426-434
Infliximab (IFX) monitoring has been proposed for effective therapeutic management of inflammatory bowel disease (IBD). There is no data on infliximab levels and its antibody measurement in Indian patients. We assessed the clinical efficacy of IFX le
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::66e2927639ee186a1d29f2fb1c643b5f
https://doi.org/10.1007/s12664-020-01050-x
https://doi.org/10.1007/s12664-020-01050-x
Autor:
Rohan V, Lokhande, Alpa J, Dherai, Ganesh R, Bhagure, Vrajesh P, Udani, Shilpa D, Kulkarni, Tester F, Ashavaid
Publikováno v:
Indian journal of pediatrics. 88(12)
Biogenic amine neurotransmitters metabolism is a multistep pathway with pterin and pyridoxal phosphate (vitamin B6) as cofactors. A defect in biogenic amine and cofactor metabolism and vesicular transporters result in a primary neurotransmitter disor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::003bf5440a646f40824a69bf29d6543f
https://pubmed.ncbi.nlm.nih.gov/34541626
https://pubmed.ncbi.nlm.nih.gov/34541626
Publikováno v:
European journal of clinical pharmacology. 77(1)
Infliximab (IFX) therapy in inflammatory bowel disease (IBD) is associated with loss of response in half the patients, due to complex pharmacokinetic and immunological factors. Dashboard's Bayesian algorithms use information from model and individual
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d9fba53bef2c9e8a91c833c1bed887b5
https://pubmed.ncbi.nlm.nih.gov/32886180
https://pubmed.ncbi.nlm.nih.gov/32886180
Autor:
Mihika B, Dave, Alpa J, Dherai, Devendra C, Desai, Bhamini G, Keny, Dhanashri N, Shetty, Satish, Kulkarni, Kiran, Peddy, Tester F, Ashavaid
Publikováno v:
Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology. 39(5)
Infliximab (IFX) monitoring has been proposed for effective therapeutic management of inflammatory bowel disease (IBD). There is no data on infliximab levels and its antibody measurement in Indian patients. We assessed the clinical efficacy of IFX le
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::17d2623a95152293f90a3ecf53a82d97
https://pubmed.ncbi.nlm.nih.gov/33191492
https://pubmed.ncbi.nlm.nih.gov/33191492
Publikováno v:
JGH Open. 1:25-31
Background and Aim A lower dose requirement and higher toxicity of thiopurine is reported in Asian patients with inflammatory bowel disease (IBD) as compared with Caucasian patients. These reports are based on thiopurine methyltransferase measurement
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0d53f1275bb3ff10205b45544dfe8bbd
https://doi.org/10.1002/jgh3.12004
https://doi.org/10.1002/jgh3.12004